On September 21, a federal court district judge ruled in favor of a lawsuit against the FDA's MOU on distribution of compounded medications between States, remanding it back to the FDA. Sit down with Philip Smyth (Director of Government & Public Affairs with Medisca), Scott Brunner (CEO for APC), and Irving Wiesen (Principal of Law Offices of Iriving L. Wiesen) who break down the significance of this pivotal ruling and what this means for compounding pharmacies.
- Күн бұрын
How Does the MOU Decision on Interstate Distribution Inspire the Future of Compounding
- Рет қаралды 403
Пікірлер